Zentalis Pharmaceuticals (ZNTL) Tax Provisions (2019 - 2026)

Zentalis Pharmaceuticals' quarterly Tax Provisions came in at $120000.0 in Q1 2026, down 72.85% quarter-over-quarter from $442000.0 in Q4 2025.

Zentalis Pharmaceuticals has reported Tax Provisions for 8 years, with the latest figure at $120000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Tax Provisions changed N/A year-over-year to $120000.0; the trailing twelve-month figure through Mar 2026 stood at $562000.0 (up 1552.94% YoY), and the FY2025 full-year result was $442000.0, up 149.72% from the prior year.
  • Tax Provisions for Q1 2026 stood at $120000.0, down from $442000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $442000.0 in Q4 2025, with the low at -$605000.0 in Q2 2023.
  • Average Tax Provisions over 5 years is -$23642.9, with a median of $24000.0 recorded in 2022.
  • Year-over-year, Tax Provisions tumbled 3658.82% in 2023 and soared 315.61% in 2025.
  • Tracing ZNTL's Tax Provisions over 5 years: stood at -$360000.0 in 2022, then soared by 62.5% to -$135000.0 in 2023, then tumbled by 51.85% to -$205000.0 in 2024, then soared by 315.61% to $442000.0 in 2025, then plunged by 72.85% to $120000.0 in 2026.
  • The last three Tax Provisions figures came in at $120000.0 (Q1 2026), $442000.0 (Q4 2025), and -$205000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Zentalis Pharmaceuticals 280.35 Mn 280.35 Mn - 120,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 120,000.00
Dec 31, 2025 442,000.00
Dec 31, 2024 -205,000.00
Sep 30, 2024 -27,000.00
Jun 30, 2024 266,000.00
Mar 31, 2024 143,000.00
Dec 31, 2023 -135,000.00
Sep 30, 2023 31,000.00
Jun 30, 2023 -605,000.00
Mar 31, 2023 108,000.00
Dec 31, 2022 -360,000.00
Sep 30, 2022 -159,000.00
Jun 30, 2022 17,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 159,000.00
Sep 30, 2021 -697,000.00
Jun 30, 2021 45,000.00
Mar 31, 2021 196,000.00
Dec 31, 2020 426,000.00
Sep 30, 2020 18,000.00
Sep 30, 2019 1,000.00
Jun 30, 2019 11,000.00
Mar 31, 2019 3,000.00